Prolor Biotech, Inc.

Project Description

CEO: Shai Novik
Headquarters: Nes Ziona, Israel
URL: www.prolor-biotech.com
Acquisition: May 2007
APO Financing: $13 Million (Acquired in April 2013 for $480 Million by OPKO Health, Inc. )
Trading Venue: Aquired

OPKO Health, Inc. is a multi-national pharmaceutical and diagnostics company that aims to establish industry-leading positions in large and rapidly growing medical markets by leveraging our discovery, development, and commercialization expertise and our novel and proprietary technologies. We intend to leverage our global commercialization expertise to pursue acquisitions of commercial businesses that will both drive our growth and provide geographically diverse sales and distribution opportunities. We have and may continue to make investments in other early stage companies that we perceive to have valuable proprietary technology and significant potential to create value for OPKO as a shareholder.